http://www.regentherapeutics.com/regen

Consider a company with a market cap of around 10 million which could well in the future be generating revenue well in excess of that figure every year. Interested then read on and DYOR on Regen Therapeutics.

For some time now I have been a shareholder of RGT who have been working with a patented product Colostrinin as a treatment for Alzheimers. Tests so far would seem to indicate that it is a success and they are currently refining a pharmaceutical product.

Meantime they are also pushing forward on the nutraceutical front as tests have shown positive results in respect of mild cognitive disorders (memory loss etc). Further research is being carried out regarding other major illnesses. As at mid 2007 a launch is scheduled in the US for Q4 and there are rumours of an earlier launch in Australia possibly imminent based on the fact that adverts are already starting to appear see:- http://www.quantumevolution.com.au/oscommerce/index.php

They have also acquired a contract research organisation which should mean that research money for clinical trials that had previously been spent will now be kept inside the group.

February 2006 has seen Regen acquire the rights, following a feasibility study, in respect of other uses for a well known drug (Zolpidem) that has undergone phase 2 clinical trials where results are expected around August 2007. The new use relates to the positive effects that have been seen when treating stroke victims with the drug. There has been a lot of press interest which a web search should reveal.

An interview with the chairman (Percy Lomax) in the summer of 2004 talked of a nutraceutical product producing royalty payments of 10% on a possible 100 million sales per annum. The pharmaceutical version which also requires a licensing partner will if successful have projected sales of 1-5 billion again which would generate royalty payments to Regen. I leave you to contemplate just how high the share price would be if this were the case but suffice to say it will be many many times what it is now.

Acquisition (Oct 2004) of Guildford Clinical Pharmacology unit demonstrates not only that they are progressive and expanding but also thinking strategically for GCPUL being a research based company no doubt Regen can now keep such costs within the group whereas before testing had to be paid for elsewhere. This acquisition also means that they have revenue and are therefore no longer a "virtual" company.

A share issue in July 2007 means that they should now have funds in hand to take them through to cash generation. Hopefully this means we have seen the last of the issues excepting any used by way of acquiring profitable companies.

The North America link is an interesting one as perhaps in readiness for the launch of Colostrinin out there Regen set up an ADR programme which became effective in March 2005. ADR's ( American Depositary Receipts) are a way for US investors to buy shares in UK companies. In Regen's case one ADR is equivalent to 200 Regen UK shares so when an ADR is purhased the Bank of New York will buy the proportionate number of UK shares and convert them into ADR's for the investor. At present this is not a factor however with the launch of Colostrinin out there if successful it may mean that US investors will want to be involved in the company and that will have a direct positive impact on our share price. In the US Colostrum (from which Colostrinin is produced )is already a recognised and popular health product and so demand should be good.

So all in all exciting times ahead. There can be few shares around that offer the potential of this one although as always DYOR and good luck with your investments whatever you decide here.

Every range is one day broken David10B - As holders we just think (and hope) it will be in the right direction.

I trust this is true for all holders queen.

Good luck, but please remember what took this to 2p a while back and how quick the bottom fell out.

A rather uninspirering day chaps-- a what!

Interesting- yesterday we heard that Regen and Metagenics appeared together promoting Colostinin at a conference in Australia sponsored by Metagenics associate company in Australia Health World. Today it seem from the link below that Metagenics Australian website is promoting Colostrinin in their "shop" section when so far the only license granted is in the US. Hopefully there is more news on the horizon:-
https://www.metagenics.com.au/shop/index.cfm?fuseaction=item&id=745

BE CAREFUL OF THE MANAGEMENT HERE!

why david

Look at the history. Check it carefully.

What's your agenda here David? You've popped up from nowhere giving an extremely one-sided view in mini-soundbites and it would be interesting for longer-term posters to this thread to know why.

No Adgenda, does one have to always have one?

Just honest comments which a rewad of the compny's histroy, cashs calls share in circulation etc will substantial.

Seems to me this company has been trying to tread water for years but is slowly sinking. I dont mean it will go bust but it should be taken over as the products are good.

That said the management lack direction.

Fair enough, thanks for your response. The products are good which is why holders have faith.

jJaguar cars are great too, but you have to get the to the punters

queen1

Do you know anything about David...if not may I suggest you do some homework on this individual, because if you do you will find out that he is very unpleasant .

On ADVFN he goes under the nickname of 10JimB and Jim_ Bentley Davis.

Good luck with RGT.

What A LOAD OF RUBBISH FORM A DISGRUNTLED UNFORTUNATE COH SHARE OWNER WHO SIMPLY COULD NOT TAKE THE EXPOSURE I GAVE HIS PET SHARE!

What a child he should be banned from all financial BBs.

Queen1 please take up the little boy's offer and do you homeworks on me, send me an email and if your are ever down in Plymstock drop by, especially if your any good at building.

BMW WHEN ARE YOU GOING TO GROW UP?

I read them all and only post here

now now you two..lets keep to the subject in hand..it seems to me that promotional exposure can only help the s.p. looking at company products and development so far.

watcher

Thanks all - I have my own "idiot" who seems to follow me around at the moment (the latest chapter in the saga is currently running on the CEN thread) so I'm happy to keep out of another one. It would be good though David if your posts could be balanced otherwise their worth may be diminished.

Good luck to all holders anyway!

queen1

Don't say I did'nt warn you.

Good luck.

Queen1, I try to balance the SP performance with time.

Conclusion RGT is not going anywhere fast.

nice to watch that strong buying pattern today..patients is a key..he he

watcher

Down I see despite all the rampings.

Be careful with this one its a money burner!

won't be down here for long if this pattern of buys continues